Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHPA pushes agency on guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA is urged to publish overdue guidance for reporting serious adverse events in an Oct. 4 letter by the American Herbal Products Association. Under the adverse event law that goes into effect Dec. 22, the guidance should have been published by Sept. 18, AHPA notes. "Congress clearly intended that businesses would have at least 90 days to digest the FDA's guidance and make any necessary changes" to comply with the law, the association says. AHPA also asks the agency to consider exercising enforcement discretion. AHPA provided FDA suggestions on the guidance in August (1"The Tan Sheet" Aug. 20, 2007, p. 13)...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100965

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel